INT8385

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.76
First Reported 1984
Last Reported 2004
Negated 0
Speculated 0
Reported most in Abstract
Documents 8
Total Number 9
Disease Relevance 2.23
Pain Relevance 1.39

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (F13a1) transferase activity, transferring acyl groups (F13a1) cytoplasm (F13a1)
Anatomy Link Frequency
plasma 1
macrophages 1
platelets 1
body 1
F13a1 (Mus musculus)
Pain Link Frequency Relevance Heat
anesthesia 9 95.92 Very High Very High Very High
analgesia 2 94.36 High High
cva 2 93.88 High High
halothane 2 92.96 High High
Pain 3 87.28 High High
Regional anesthesia 4 75.12 Quite High
Restless leg syndrome 4 50.00 Quite Low
Disease Link Frequency Relevance Heat
Cancer 3 99.28 Very High Very High Very High
Anaemia 1 98.42 Very High Very High Very High
Neurothekeoma 3 96.48 Very High Very High Very High
Renal Failure 1 95.24 Very High Very High Very High
Thrombosis 3 93.92 High High
Cv General 3 Under Development 2 93.88 High High
Body Weight 1 93.64 High High
Hematuria 1 90.92 High High
Hematoma 1 90.36 High High
Pain 1 87.28 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Approximately 20% of the interstitial cells were dendritic macrophages characterized by phagocytic activity, presence of many lysosomes, and Factor XIIIa expression.
Gene_expression (expression) of Factor XIIIa in macrophages
1) Confidence 0.76 Published 1992 Journal Am. J. Clin. Pathol. Section Abstract Doc Link 1372149 Disease Relevance 0.53 Pain Relevance 0.06
Pre- and postoperatively as well as at the 1st, 3rd, 5th, and 7th p.o. day the plasma levels of factor XIII, fibrinogen (factor I) and fibrinogen-degradation-products (FDP) were measured.
Gene_expression (levels) of factor XIII in plasma
2) Confidence 0.43 Published 1984 Journal Anaesthesist Section Abstract Doc Link 6721127 Disease Relevance 0 Pain Relevance 0.37
The levels of factor XIII remained within the normal range.
Gene_expression (levels) of factor XIII
3) Confidence 0.33 Published 1984 Journal Anaesthesist Section Abstract Doc Link 6721127 Disease Relevance 0 Pain Relevance 0.37
Hematological tests show: mild anemia with leucocytosis; prolonged PT, PTT and ThT; decreased fibrinogen, factor V, factor XIII, plasminogen and alpha2-antiplasmin levels; increased factor VIII:c, von Willebrand factor, and FDPs/D-dimers levels with normal ATIII and platelets.
Gene_expression (levels) of factor XIII in platelets associated with anaemia
4) Confidence 0.06 Published 2000 Journal Biochimie Section Abstract Doc Link 11086223 Disease Relevance 0.71 Pain Relevance 0.13
Additional information is obtained about fibrinogen and Factor XIII levels as well as the fibrinolytic system.
Gene_expression (levels) of Factor XIII
5) Confidence 0.05 Published 1991 Journal Reg Anesth Section Abstract Doc Link 2007109 Disease Relevance 0.08 Pain Relevance 0.28
Neither factor XIIIa nor epithelial membrane antigen (EMA) expression was found in the tumor cells.
Gene_expression (expression) of XIIIa associated with cancer
6) Confidence 0.05 Published 1992 Journal Acta Med Port Section Abstract Doc Link 1595376 Disease Relevance 0.44 Pain Relevance 0.09
CONCLUSIONS: The healthy male relatives of men with PAD have elevated levels of fibrinogen, factor VII, and factor XIII.
Gene_expression (levels) of factor XIII
7) Confidence 0.02 Published 2004 Journal J. Vasc. Surg. Section Body Doc Link 15557902 Disease Relevance 0.06 Pain Relevance 0
Primary outcome measures were fibrinogen, von Willebrand factor, factor VII clotting activity (FVII:C), and factor XIII levels.
Gene_expression (levels) of factor XIII
8) Confidence 0.02 Published 2004 Journal J. Vasc. Surg. Section Body Doc Link 15557902 Disease Relevance 0.08 Pain Relevance 0
Coagulation parameters such as prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration, platelet count, fibrin monomers, D-dimers, antithrombin III and factor XIII activities, thrombelastography, and platelet aggregometry were measured during a 4-h period after sequential double endotoxin administration (80 and 40 micrograms/kg of body weight, intravenously).
Gene_expression (activities) of factor XIII in body associated with body weight
9) Confidence 0.02 Published 1995 Journal Lab. Anim. Sci. Section Abstract Doc Link 8569153 Disease Relevance 0.33 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox